Delivery Order SPE2DB22D1106-SPE2DB24FESV5
Award Date 5/21/24
Potential Completion Date 5/22/24
Potential Value $2.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $7,317.86 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. This order is for 4,565,152,638 units of the drug Humalog (insulin lispro) in 10 mL vials, with a performance period through July 16, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Humalog insulin vials. The $1,639.44 firm-fixed-price contract has a completion date of May 22, 2024. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award, with ID SPE2DB22D3004|SPE2DB24FQL04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,092.96 firm fixed-price delivery order is for the supply of Humalog 100 unit/mL insulin vials. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Humalog 100 Unit/mL insulin vials, with a ceiling value of $2,732.40 and a completion date of January 20, 2023. The contract is a firm fixed price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order under a Defense Logistics Agency (DLA) Indefinite Delivery Contract for the supply of Humalog 100 Unit/mL insulin vials. The $1,092.96 contract has a firm fixed price and an ultimate completion date of August 23, 2024. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including specialty...
- The Defense Logistics Agency awarded a $1,943.94 delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/mL vials (10mL units), with an ultimate completion date of August 27, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,177.75 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/ML vials (10 ML) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency (DLA) awarded a $1,387.40 delivery order to AmerisourceBergen Drug Corp for 10 mL vials of Humalog 100 Unit/mL insulin, with an ultimate completion date of October 20, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an existing contract vehicle. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a delivery order under a federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Humalog 100 Unit/mL vial (10 mL), a type of insulin medication. The delivery order has a ceiling value of $1,821.60 and a completion date of September 24, 2024. This contract is not set aside for any specific business category. As a large pharmaceutical supplier,...
- The Defense Logistics Agency awarded a delivery order valued at $1,413.30 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/mL vials (10mL) on August 21, 2025, with an ultimate completion date of August 22, 2025. This contract represents a firm fixed price, non-set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The...